Treatment with Weak Electromagnetic Fields Improves Fatigue Associated with Multiple Sclerosis

References

• Aldegunde M., Miguez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Allen R. M. Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: overview and pharmacology. Clinical Neuropharmacology 1983; 6: S64–S73
   PubMedGoogle Scholar
• Arana G. W., Hyman S. E. Handbook of psychiatric drug therapy. Little, Brown and Company, Boston 1991; 162–170
   Google Scholar
• Bailey E. V., Stone T. W. The mechanism of action of amantadine in parkinsonism: a review. Archives of International Pharmacodynamics and Therapeutics 1975; 216: 246–262
   PubMedGoogle Scholar
• Baldessarini R. J., Lipinski J. F., Chace K. V. Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat. Biochemical Pharmacology 1972; 21: 77–87
   PubMed Web of Science ®Google Scholar
• Bawin S. M., Adey W. R. Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proceedings of the National Academy of Sciences, USA 1976; 73: 1999–2003
   PubMed Web of Science ®Google Scholar
• Blackman C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss, New York 1988
   Google Scholar
• Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the mid-brain can regulate dopamine function both behaviourally and biochemically. The pineal gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 327–332
   Google Scholar
• Burton S., Daya S., Potgieter B. Melatonin modulates apomorphine-induced rotational behavior. Experientia 1991; 47: 466–469
   PubMedGoogle Scholar
• Cardinali D. P. Changes in hypothalamic neurotransmitter uptake following pinealectomy, superior cervical ganglionectomy or melatonin administration to rats. Neuroendocrinology 1975; 19: 91–95
   PubMed Web of Science ®Google Scholar
• Clark C. M., Fleming J. A., Li D., Oger J., Klonoff H., Paty D. Sleep disturbance, depression, and lesion site in multiple sclerosis. Archives of Neurology 1992; 49: 641–643
   PubMedGoogle Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Cremer-Bartels G., Krause K., Kuechle H. J. Influence of low magnetic field-strength variations on the retina and pineal gland of quails and humans. Graefe's Archives of Clinical and Experimental Ophthalmology 1983; 220: 248–252
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Davis F. A., Jacobson S. Altered thermal sensitivity in injured and demyelinated nerve. Journal of Neurology Neurosurgery and Psychiatry 1971; 34: 551–561
   PubMed Web of Science ®Google Scholar
• Demaine C., Semm P. The avian pineal gland as an independent magnetic sensor. Neuroscience Letters 1985; 62: 119–122
   PubMed Web of Science ®Google Scholar
• Dixey R., Rein G. 3H-noradrenaline release potentiated in a clonal nerve cell line by low-intensity pulsed magnetic field. Nature 1982; 296: 253–256
   PubMed Web of Science ®Google Scholar
• Dubocovich M. L. Melatonin as a potent modulator of dopamine release in the retina. Nature 1983; 306: 782–784
   PubMed Web of Science ®Google Scholar
• Freal J. E., Kraft G. H., Coryell J. K. Symptomatic fatigue in multiple sclerosis. Archives of Physical Medicine and Rehabilitation 1984; 65: 135–138
   PubMed Web of Science ®Google Scholar
• Harrer G. Is the neurotransmitter system abnormal in multiple sclerosis. Geriatric Medicine 1973; 3: 116–117
   Google Scholar
• Harrer G., Fischbach R. Ueber die wirkung bestimmter Aminosauren auf das Ergebnis des Uenberwarmungstests bei Multiple Sklerose Kranken. Journal of Neural Transmission 1973; 34: 205–214
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Jolma T., Riekkinen P., Rinne U. K. Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Jaffe R. A., Laszewski B. L., Carr D. B., Phillips R. D. Chronic exposure to a 60-Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioelectromagnetics 1980; 1: 131–147
   PubMedGoogle Scholar
• Johansson B., Roos B. E. 5-hydroxyindoleacetic acid in cerebrospinal fluid of patients with neurological diseases. European Neurology 1974; 11: 37–45
   PubMed Web of Science ®Google Scholar
• Jones D. G., Tumbull M. J., Lenman J. A. Effects of amantadine on the urinary excretion of some monoamines and metabolites in normal and Parkinsonian subjects. Journal of Neurological Sciences 1972; 17: 245–253
   PubMedGoogle Scholar
• Kisser W., Harrer G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Krupp L. B., Coyle P. K., Cross A. H., Dermit S., Friedman R. Amelioration of fatigue with pemoline in patients with multiple sclerosis. Annals of Neurology 1989; 26: 155–156
   Web of Science ®Google Scholar
• Marsden C. D., Parkes J. D. “On and off” variability and response swings in Parkinson's disease. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Kent 1980; 265–274
   Google Scholar
• Miguez J. M., Martin F., Aldegunde M. Differential effects of pinealectomy on amygdala and hippocampus serotonin metabolism. Journal of Pineal Research 1991a; 10: 100–103
   PubMed Web of Science ®Google Scholar
• Miguez J. M., Martin F., Aldegunde M. Long-term pinealectomy alters hypothalamic serotonin metabolism in the rat. Journal of Pineal Research 1991b; 11: 75–79
   PubMed Web of Science ®Google Scholar
• Miguez J. M., Martin F. J., Aldegunde M. Effects of single doses and daily melatonin treatments on serotonin metabolism in rat brain regions. Journal of Pineal Research 1994; 17: 170–176
   PubMed Web of Science ®Google Scholar
• Miledi R. Transmitter release induced by injection of calcium ions into nerve terminals. Proceedings of the Royal Society of Biological Sciences 1973; 183: 421–428
   PubMed Web of Science ®Google Scholar
• Murray T. J. The treatment of fatigue in MS. Neurology 1984; 34: 139, (suppl)
   PubMed Web of Science ®Google Scholar
• Murray T. J. Amantadine therapy for fatigue in multiple sclerosis. Canadian Journal of Neurological Sciences 1985; 12: 251–254
   PubMed Web of Science ®Google Scholar
• Nelson D. A., McDowell F. The effects of induced hyperthermia on patients with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1959; 22: 113–116
   PubMed Web of Science ®Google Scholar
• Olcese J. M., Hall T. R., Figueroa H. R., DeVlaming V. L. Pinealectomy and melatonin effects on daily variations of the hypothalamic serotonergic system in the goldfish. Comparative Biochemistry and Physiology 1981; 704: 69–72
   Google Scholar
• Pazo J. H. Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Research Bulletin 1979; 4: 725–730
   PubMed Web of Science ®Google Scholar
• Plaut G. S. Effectiveness of amantadine in reducing relapses in multiple sclerosis. Journal of the Royal Society of Medicine. 1987; 80: 91–93
   PubMed Web of Science ®Google Scholar
• Reichardt L. F., Kelly R. B. A molecular description of nerve terminal function. Annual Review of Biochemistry 1983; 52: 871–926
   PubMed Web of Science ®Google Scholar
• Reiter R. J., Richardson B. A. Magnetic fields of effects on pineal indoleamine metabolism and possible biological consequences. FASEB Journal 1992; 6: 2283–2287
   PubMed Web of Science ®Google Scholar
• Rosen A. D., Lubowsky J. Magnetic field influence on central nervous system function. Experimental Neurology 1987; 95: 679–687
   PubMed Web of Science ®Google Scholar
• Rosenberg G. A., Appenzeller O. Amantadine, fatigue, and multiple sclerosis. Archives of Neurology 1988; 45: 1104–1106
   PubMed Web of Science ®Google Scholar
• Rudick R. A., Goodkin D. E., Ransohoff R. M. Pharmacotherapy of multiple sclerosis: current status. Cleveland Clinic Journal of Medicine 1992; 59: 267–277
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992a; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. The pineal gland and multiple sclerosis. (Editorial). International Journal of Neuroscience 1992b; 63: 206–215
   Web of Science ®Google Scholar
• Sandyk R. Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience 1993; 72: 141–148
   PubMedGoogle Scholar
• Sandyk R. Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience 1994; 77: 243–259
   PubMed Web of Science ®Google Scholar
• Sandyk R. Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields. International Journal of Neuroscience 1995; 82: 223–242
   PubMed Web of Science ®Google Scholar
• Sandyk R. Premenstrual exacerbation of symptoms in multiple sclerosis is attenuated by treatment with weak electromagnetic fields. International Journal of Neuroscience., (in press)
   Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience 1993a; 68: 241–253
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience 1993b; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Pineal calcification and its relationship to the fatigue of multiple sclerosis. International Journal of Neuroscience 1994; 74: 95–103
   PubMedGoogle Scholar
• Sandyk R., Dann L. C. Weak electromagnetic fields attenuate tremor in multiple sclerosis. International Journal of Neuroscience 1994; 79: 199–212
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Improvement by picotesla magnetic fields of perceptual-motor performance in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience 1994; 78: 53–66
   PubMed Web of Science ®Google Scholar
• Sandyk R., Dann L. C. Resolution of Lhermitte's sign in multiple sclerosis by treatment with weak electromagnetic fields. International Journal of Neuroscience 1995; 81: 215–224
   PubMed Web of Science ®Google Scholar
• Scatton B., Cheramy A., Besson M. J., Glowinsky J. Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment. European Journal of Pharmacology 1970; 13: 131–133
   PubMed Web of Science ®Google Scholar
• Scheinberg L., Holland N., La Rocca N., Laitin P., Bennett A., Hall H. Multiple sclerosis: earning a living. New York State Journal of Medicine 1980; 80: 1395–1400
   PubMedGoogle Scholar
• Schwab R. S., England A. C., Peterson E. Akinesia in Parkinson's disease. Neurology 1959; 9: 65–72
   PubMedGoogle Scholar
• Schwab R. S., England A. C, Poskanzer D. C., Young R. R. Journal of the American Medical Association 1969; 208: 1168–1170
   PubMed Web of Science ®Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Smith C. R., Scheinberg L. C. Clinical features of multiple sclerosis. Seminars in Neurology 1985; 5: 85–93
   Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Sugden D., Morris R. D. Changes in regional brain levels of tryptophan, 5-hydroxytryptamine, 5-hydroxyindoleacetic acid, dopamine and noradrenaline after pinealectomy in the rat. Journal of Neurochemistry 1979; 32: 1593–1595
   PubMed Web of Science ®Google Scholar
• Symington G. R., MacKay I. R., Currie T. T. Improvement in multiple sclerosis during prolonged induced hypothermia. Neurology 1977; 27: 302–303
   PubMed Web of Science ®Google Scholar
• Tabaddor K., Wolfson L. I., Sharpless N. S. Ventricular fluid homovanillic acid and 5-hydroxyin-doleacetic acid concentrations in patients with movement disorders. Neurology 1978; 28: 1249–1253
   PubMed Web of Science ®Google Scholar
• Terzano M. G., Montanari E., Calzetti S., Mancia D., Lechi A. The effect of amantadine on arousal and EEG patterns in Creutzfeldt-Jakob disease. Archives of Neurology 1983; 40: 555–559
   PubMedGoogle Scholar
• Vardi J., Streifler M. On the synchronizing effect of amantadine-1-hydrochloride on pathological EEG activity. Journal of Neural Transmission 1975; 37: 73–80
   PubMedGoogle Scholar
• Von Voigtlander P. F., Moore K. E. Dopamine: release from the brain in vivo by amantadine. Science 1971; 174: 408–410
   PubMedGoogle Scholar
• Waxman S. G. Pathophysiology of multiple sclerosis. Handbook of multiple sclerosis, S. D. Cook. Marcel Dekker, New York 1990; 219–250
   Google Scholar
• Weinshenker B. G., Penman M., Bass B., Ebers G. C, Rice G. P. A. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 1992; 42: 1468–1471
   PubMed Web of Science ®Google Scholar
• White R. F. Emotional and cognitive correlates of multiple sclerosis. Journal of Neuropsychiatry 1990; 2: 422–428
   PubMedGoogle Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C, Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Chess E. K., Anderson L. E. 60-Hz electric-field effects on pineal melatonin rhythms: time course for onset and recovery. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Neuroendocrine mediated effects of electromagnetic field exposure: possible role of the pineal gland. Life Sciences 1989; 45: 1319–1332
   PubMed Web of Science ®Google Scholar